510(k) Report

510(k) · Cleared

Cleared

Ultraverse 014 and 018 PTA Balloon Dilatation Catheters

K192318510(k) TraditionalCleared Oct 3, 201938-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bard Peripheral Vascular, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Oct 3, 2019 as substantially equivalent to K121856 (C.R. Bard, Inc., 2012) after a 38-day review. Its family tree reaches back 3 generations to 2001. 1 later device descends from it.

Decided
Oct 3, 2019
Review
38 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K012913 (2001). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK012913 Bard Utaverse Small Vessel Pta Balloon Dilatation CatheterC.R. Bard, Inc. · 2001
  2. 2 generations backK093965 Ultraverse 014 and 018 Balloon Dilatation CathetersC.R. Bard, Inc. · 2010
  3. 1 generation backK121856 Ultraverse 014 and 018 Pta Balloon Dilatation Catheters Line ExtensionC.R. Bard, Inc. · 2012
  4. This deviceK192318 Ultraverse 014 and 018 PTA Balloon Dilatation CathetersBard Peripheral Vascular, Inc. · 2019
  5. Descendant · cites it directly · 0 of its ownK223177 Highlander™ 014 PTA Balloon Dilatation CatheterC.R. Bard, Inc. · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K223177Highlander™ 014 PTA Balloon Dilatation CatheterC.R. Bard, Inc. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K012913Bard Utaverse Small Vessel Pta Balloon Dilatation CatheterC.R. Bard, Inc.2001—
−2K093965Ultraverse 014 and 018 Balloon Dilatation CathetersC.R. Bard, Inc.2010—
−1K121856Ultraverse 014 and 018 Pta Balloon Dilatation Catheters Line ExtensionC.R. Bard, Inc.2012—
0 (this device)K192318Ultraverse 014 and 018 PTA Balloon Dilatation CathetersBard Peripheral Vascular, Inc.2019—
+1K223177Highlander™ 014 PTA Balloon Dilatation CatheterC.R. Bard, Inc.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K192318, 2001–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121856Ultraverse 014 and 018 Pta Balloon Dilatation Catheters Line Extension
Summary page 4
…Cardiovascular Regulation Number: 21 CFR 870.1250 Predicate Device:  Ultraverse® 014 and 018 PTA Balloon Dilatation Catheters (K121856; cleared July 11, 2012) Reference Device:  Ultraverse® 035 PTA Balloon Dilatation Catheters (K142261; cleared…
C.R. Bard, Inc.2012—
†K142261Ultraverse 035 PTA Balloon Dilatation CatheterBard Peripheral Vascular, Inc.2014—

Also cleared against K121856: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223177Highlander™ 014 PTA Balloon Dilatation CatheterC.R. Bard, Inc.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 2 companies; a new generation was cleared every 7.2 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K223177 (C.R. Bard, Inc., 2023) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K121856.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

Ultraverse® 014 and Ultraverse® 018 PTA Balloon Dilatation Catheters are recommended for use in percutaneous trasluminal angioplasty (PTA) of the renal, popliteal, tibial, femoral, and peroneal arteries. These catheters are not for use in coronary arteries.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K192318: Ultraverse 014 and 018 PTA Balloon Dilatation Catheters.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K192318

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026